17 reports of this reaction
3.0% of all ANTIFUNGAL LIQUID SPRAY reports
#1 most reported adverse reaction
ARTHRALGIA is the #1 most commonly reported adverse reaction for ANTIFUNGAL LIQUID SPRAY, manufactured by ARMY & AIR FORCE EXCHANGE SERVICE. There are 17 FDA adverse event reports linking ANTIFUNGAL LIQUID SPRAY to ARTHRALGIA. This represents approximately 3.0% of all 575 adverse event reports for this drug.
Patients taking ANTIFUNGAL LIQUID SPRAY who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for ANTIFUNGAL LIQUID SPRAY, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for ANTIFUNGAL LIQUID SPRAY:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 17 FDA reports for ANTIFUNGAL LIQUID SPRAY. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 3.0% of all adverse event reports for ANTIFUNGAL LIQUID SPRAY, making it one of the most commonly reported side effect.
If you experience arthralgia while taking ANTIFUNGAL LIQUID SPRAY, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.